Intestinal evisceration is a rare event and few cases of colostomy rupture have been documented in the medical literature. Complications of colostomy surgery vary in incidence, with most episodes occurring in the immediate postoperative timeframe, including necrosis, hemorrhage, cellulitis and dehiscence. Here, we document the case of a 35-year-old male patient with a history of immunodeficiency, multiple comorbidities and squamous cell carcinoma of the anus who experienced a unique instance of colostomy evisceration weeks after initial surgery. The patient originally underwent surgery for a sigmoid colostomy for the alleviation of irritation secondary to anal disease. Weeks later, after a traumatic fall injury, he experienced colostomy evisceration. This case will review the factors leading up to this event that put the patient at risk for poor wound healing and ultimately colostomy rupture.
Sporadic Burkitt’s Lymphoma accounts for only 1–2% of Non Hodgkin’s Lymphoma, and metastasizes to the central nervous system (CNS) is uncommon, occurring in about 13–17% of adult patients. 1 Melanoma is far more likely to metastasize to the CNS, occurring in about 37% of adult patients.2 Here we present the case of a 69 year old Gambian female with a prior medical history of plantar melanoma. She initially presented to her primary care provider with back pain and adenopathy, and was referred to surgical consultation for diagnosis and concern for recurrent melanoma. Her workup revealed metastatic Burkitt’s Lymphoma with disease in the abdomen, lungs and likely CNS involvement. This report chronicles her disease course and approach to management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.